Bare fiber photodynamic therapy using porfimer sodium for esophageal disease

Photodiagnosis and Photodynamic Therapy - Tập 3 - Trang 87-92 - 2006
Herbert Wolfsen1,2,3,4,5,6,7,8,9,10, Marcia Canto1,2,3,4,5,6,7,8,9,10, Bob Etemad1,2,3,4,5,6,7,8,9,10, Bruce Greenwald4, Frank Gress1,2,3,4,5,6,7,8,9,10, Drew Schembre1,2,3,4,5,6,7,8,9,10, V. Raman Muthusamy1,2,3,4,5,6,7,8,9,10, Afonso Ribeiro1,2,3,4,5,6,7,8,9,10, Virender Sharma1,2,3,4,5,6,7,8,9,10, Gregory Ginsberg1,2,3,4,5,6,7,8,9,10
1Divisions of Gastroenterology and Hepatology, Mayo Clinic, 6A Davis Bldg., 4500 San Pablo Road, Jacksonville, FL 32224, USA
2Divisions of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA
3Divisions of Gastroenterology and Hepatology, Ochsner Clinic, New Orleans, LA, USA
4Divisions of Gastroenterology and Hepatology, University of Maryland, Baltimore, MD, USA
5Divisions of Gastroenterology and Hepatology, Duke University, Durham, NC, USA
6Divisions of Gastroenterology and Hepatology, Virginia Mason Medical Center, Seattle, WA, USA
7Divisions of Gastroenterology and Hepatology, University of California, San Francisco, CA, USA
8Divisions of Gastroenterology and Hepatology, University of Miami, Miami, FL, USA
9Divisions of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA
10Divisions of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA

Tài liệu tham khảo

Wolfsen, 2005, Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus, J Clin Gastroenterol, 39, 189, 10.1097/01.mcg.0000152748.56902.02 Wolfsen, 2005, Carpe luz-seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium, Gastrointest Endosc, 62, 499, 10.1016/j.gie.2005.07.017 Overholt, 2005, Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial, Gastrointest Endosc, 62, 488, 10.1016/j.gie.2005.06.047 Laukka, 1995, Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus, Gastrointest Endosc, 42, 59, 10.1016/S0016-5107(95)70245-8 Prosst, 2003, Photodynamic therapy for esophageal diseases: a clinical update, Endoscopy, 35, 1059, 10.1055/s-2003-44604 Lovat, 2005, Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus, Gastrointest Endosc, 62, 617, 10.1016/j.gie.2005.04.043 Mlkvy, 1998, Photodynamic therapy for gastrointestinal tumors using three photosensitizers—ALA induced PPIX, Photofrin and m-THPC. A pilot study, Neoplasma, 45, 157 Sharma, 2004, A randomized trial of radio-frequency ablation of specialized intestinal metaplasia of the esophagus, Gastrointest Endosc, 59, AB113, 10.1016/S0016-5107(04)00554-1 Panjehpour, 2000, Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract, Gastrointest Endosc Clin N Am, 10, 513, 10.1016/S1052-5157(18)30120-X Wang, 2005, American gastroenterological association technical review on the role of the gastroenterologist in the management of esophageal carcinoma, Gastroenterology, 128, 1471, 10.1053/j.gastro.2005.03.077 Wallace, 2000, Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy, Gastroenterology, 119, 677, 10.1053/gast.2000.16511 Noh, 2005, Fine needle aspiration of peritumoral lymph nodes in esophageal cancer with endobronchial ultrasound, Am J Gastroenterol, 100, S262, 10.14309/00000434-200509001-00698 Noh, 2005, Emerging endoscopic techniques in oncology, Gastrointest Endosc Clin N Am, 15, 615, 10.1016/j.giec.2005.03.001 Cameron, 1995, Adenocarcinoma of the esophagogastric junction and Barrett's esophagus, Gastroenterology, 109, 1541, 10.1016/0016-5085(95)90642-8 Wang, 2005, Current Strategies in the management of Barrett's esophagus, Curr Gastroenterol Rep, 7, 196, 10.1007/s11894-005-0034-9 Dougherty, 1998, Photodynamic therapy, J Natl Cancer Inst, 90, 889, 10.1093/jnci/90.12.889 Georgakoudi, 1997, The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry, Photochem Photobiol, 65, 135, 10.1111/j.1751-1097.1997.tb01889.x Sampliner, 2004, Endoscopic ablative therapy for Barrett's esophagus: current status, Gastrointest Endosc, 59, 66, 10.1016/S0016-5107(03)02380-0 Overholt, 2000, Acid suppression and reepithelialization after ablation of Barrett's esophagus, Dig Dis, 18, 232, 10.1159/000051404 Ukleja, 1999, Nutritional consequences following photodynamic therapy, Gastrotenterology, 116, A-582 Ban, 2004, Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus, Am J Surg Pathol, 28, 1466, 10.1097/01.pas.0000141392.91677.7f Hemminger, 2002, Photodynamic therapy for Barrett's esophagus and high grade dysplasia: results of a patient satisfaction survey, Gastroenterol Nurs, 25, 139, 10.1097/00001610-200207000-00002 Wolfsen, 2002, Cutaneous consequences of photodynamic therapy, Cutis, 69, 140 Wolfsen, 2004, Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer, Aliment Pharmacol Ther, 20, 1125, 10.1111/j.1365-2036.2004.02209.x Wang, 2000, Complications of photodynamic therapy in gastrointestinal disease, Gastrointest Endosc Clin N Am, 10, 487, 10.1016/S1052-5157(18)30118-1 Panjehpour, 2005, Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment, Gastrointest Endosc, 61, 13, 10.1016/S0016-5107(04)02394-6 Sujendran, 2005, Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus, Eur J Cardiothorac Surg, 28, 763, 10.1016/j.ejcts.2005.08.018